Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy

Volumn 27, Issue 5, 2013, Pages 371-380

  Dai, Yao ^a   Mehta, Jawahar L ^a   Chen, Mingwei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GLP1R PROTEIN, HUMAN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIRAGLUTIDE; NOS3 PROTEIN, HUMAN; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOLOL MYRISTATE ACETATE;

AGONISTS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

CELLS, CULTURED; ENDOTHELIN-1; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; LIRAGLUTIDE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, GLUCAGON; TETRADECANOYLPHORBOL ACETATE;

EID: 84899467577     PISSN: None     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-013-6463-z     Document Type: Article

References (0)